Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia

Journal of Hematotherapy and Stem Cell Research

Volumn 6, Issue 5, 1997, Pages 495-500

  Vervoordeldonk, Susan F ^a,d   Van Den Berg, Henk ^b   Von Dem Borne, Albert E G Kr ^c   Van Leeuwen, Eleonore F ^b   Slaper Cortenbach, Ineke C M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY CD 10; MONOCLONAL ANTIBODY CD 19; MONOCLONAL ANTIBODY CD 22; MONOCLONAL ANTIBODY CD 72; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REMISSION; STEM CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; TRANSPLANTATION, AUTOLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030780207     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1997.6.495     Document Type: Article

References (13)

1. Slaper-Cortenbach, I.C.M., Admiraal, L.G., van Leeuwen, E.F., et al. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis. Exp. Hematol. 18:49, 1990.
2. Vervoordeldonk, S.F., Merle, P.A., Behrendt, H., et al. PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukemia. Br. J. Haematol. 96:395, 1997.
3. Beishuizen, A., Hahlen, K., Hagemeijer, A., et al. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia 5:657, 1991.
4. Vervoordeldonk, S.F., Merle, P.A., van Leeuwen, E.F., et al. Preclinical studies with radiolabeled B cell McAbs for treatment of patients with B cell malignancies. Cancer 72:1006, 1994.
5. Schwarting, R., Castello, R., Moldenhauer, G., et al. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias. Am. J. Hematol. 41:151, 1992.
6. Lansdorp, P.M., Aalberse, R.C., Bos, R., et al. Cyclic tetramolecular complexes of monoclonal antibodies: A new type of cross-linking reagent. Eur. J. Immunol. 16:679, 1986.
7. Bast, C., De Fabritiis, P., Lipton, J., et al. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res. 45:499, 1985.
8. Vervoordeldonk, S.F., Merle, P.A., Steenbergen, E.J., et al. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. In Advances in Bone Marrow Purging and Processing: Fourth International Symposium, ed. Gee, A. Wiley-Liss, New York, 1994, p. 601.
9. Garcia, J., Punti, C., Picon, M., et al. Bone marrow purging in acute lymphoblastic leukemia: Biological and clinical features. J. Hematother. 3:203, 1994.
10. Uckun, F.M., Kersey, J.H., Haake, R., et al. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood 79:1094, 1992.
11. Kara, T., Kojima, A., Fukuda, H., et al. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies. Br. J. Haematol. 82:368, 1992.
12. Fukuda, H., Seya, T., Hara, T., et al. Deficiency of complement decay-accelarating factor (DAF,CD55) in non-Hodgkin's lymphoma. Immunol. Lett. 29:205, 1991.
13. Morgan, B.P. & Meri, S. Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15:369, 1994.